Earnings Call · Q2 FY2026·2026-08-06

Q2 26EPS -100.00%*·Rev n/aQ1 26EPS -17.24%·Rev n/aQ4 25EPS +43.72%·Rev n/aQ3 25EPS +100.00%*·Rev n/a⚠ consensus missing

Organogenesis Holdings Inc. ORGO

Gary S. Gillheeney Sr. — President, Chief Executive Officer, and Chair of the Board

David Francisco — Chief Financial Officer

−22.8%1d on move date3d−21.6%5d−27.0%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ORGO calls or request research access.

More ORGO calls Browse calls Request research access